<b>Objective</b>: To investigate the effect of GLP-1 agonists, including dual and triple agonists, in patients with metabolic-associated liver steatosis and steatohepatitis, while exploring their effect on patients with and without type 2 diabetes. The gene discussed is GCG; the disease is type 2 diabetes mellitus.